India making progress in medicine: USFDA

Visakhapatnam: Director of Drug Quality Division, USFDA Dr Carmelo Rosa on Thursday said that India is making continuous progress in the field of medicine.

He was speaking after inaugurating a two-day workshop on ‘Current Good Manufacturing Practices’ jointly organised by Andhra University and USFDA here.

He said that continuous efforts should be made to manufacture quality medicines. It is very necessary to follow better and quality manufacturing methods. He said that the laws are being implemented by making necessary changes. Regulators are also facing many challenges. He explained how the FDA works to provide safe, quality pharmaceutical and food products to America. Awareness is created on the laws being implemented at different stages of drug preparation, approvals and consumption.

He said that there is a need for the industries to know the regulations in the preparation of medicine thoroughly. The objective is to ensure that quality medicines are available to the people. He clarified that FDA rules must be strictly followed by pharmaceutical industries.

International Relations Specialist (Drugs), USFDA India Gregory Smith said that public health is the highest priority of FDA. He said that the FDA will provide guidance, monitoring, testing, regulatory and other services for the manufacture of medicines and food products with the best standards. They are working in connection with different industries.

He said the world has become more connected as a result of globalization. He said that consumers today have the opportunity to get their preferred brand of medicine. He said that Andhra Pradesh has a special position in FDA India office. By 2021, there were 331 companies manufacturing medicines in India with FDI recognition.